Skip to main content

Best Medical Oncology specialists in Massachusetts

Match with a top Medical Oncology specialist in Massachusetts — priority appointment in days, not months.

Medical Oncology · Massachusetts
Ursula Matulonis

Ursula Matulonis, MD

Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute

Oncology

Boston, MA
Robert Haddad

Robert Haddad, MD

Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School

Oncology

Boston, MA
Patrick Ott

Patrick Ott, MD

Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician

Oncology

Boston, MA
Kenneth Anderson

Kenneth Anderson, MD

Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Boston, MA
Mary-Ellen Taplin

Mary-Ellen Taplin, MD

Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Oncology

Boston, MA
Toni Choueiri

Toni Choueiri, M.D.

Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School

Oncology

Milford, MA
Ann Lacasce

Ann Lacasce, M.D.

Associate Professor of Medicine, is a lymphoma specialist and is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. She serves

Oncology

Milford, MA
Vincent Ho

Vincent Ho, MD

Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute

Oncology

Boston, MA
Susana Campos

Susana Campos, MD MPH

Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School

Oncology

Boston, MA
Suzanne George

Suzanne George, MD

Chief, Division of Sarcoma; Clinical Research Director, Sarcoma Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Boston, MA
Himisha Beltran

Himisha Beltran, MD

Associate Professor of Medicine, Lank Center for Genitourinary Oncology and Division of Molecular and Cellular Oncology; Director of Translational Research, Medical Oncology

Oncology

Boston, MA
Joseph Antin

Joseph Antin, MD

Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus

Oncology

Boston, MA
Jennifer Chan

Jennifer Chan, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute

Oncology

Boston, MA
Geoffrey Shapiro

Geoffrey Shapiro, MD PHD

Senior Vice President, Developmental Therapeutics; Clinical Director, Center for DNA Damage and Repair; Professor of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute

Oncology

Boston, MA
Robert Soiffer

Robert Soiffer, MD

Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School

Oncology

Boston, MA
Matthew Smith

Matthew Smith, MD PHD

Professor of Medicine, Harvard Medical School; Director, Genitourinary Oncology Program, Massachusetts General Hospital Cancer Center

Oncology

Boston, MA
Harold Burstein

Harold Burstein, MD PHD

Director of Academic Partnerships; Director of Breast Cancer Education

Oncology

Boston, MA
Arnold Freedman

Arnold Freedman, MD

Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School

Oncology

Boston, MA
Janet Abrahm

Janet Abrahm, MD

Professor of Medicine, Harvard Medical School; Chief Resident

Oncology

Boston, MA
Erica Mayer

Erica Mayer, MD MPH

Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School; Director, Breast Cancer Clinical Research, Dana-Farber Breast Oncology Program

Oncology

Boston, MA

Frequently Asked Questions

What does a Medical Oncology oncologist do?
A Medical Oncology oncologist is a Oncology physician with focused training in the systemic treatment of cancer with chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. After completing Oncology residency, they pursue additional fellowship training so they can manage cases that fall outside what a general oncologist typically handles day to day.
What conditions does a Medical Oncology oncologist treat?
A Medical Oncology oncologist commonly treats breast cancer, colorectal cancer, lung cancer, lymphomas, melanoma, and pancreatic cancer. Many also see closely related conditions within Oncology, particularly when a case is complex, atypical, or has not responded to first-line care from a general oncologist.
When should I see a Medical Oncology oncologist?
Consider seeing a Medical Oncology oncologist when you have a new cancer diagnosis or your treatment plan involves systemic therapy, when a primary care clinician or general oncologist suggests a focused evaluation, or when you want a second opinion from a physician whose practice is concentrated on this exact area. Patients often reach a Medical Oncology oncologist through referral, but you can also seek one directly.
How is a Medical Oncology oncologist different from a general oncologist?
Both are board-eligible oncologists, but a Medical Oncology oncologist has additional fellowship training and a practice that focuses on the systemic treatment of cancer with chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. General oncologists treat a broad range of Oncology concerns; Medical Oncology oncologists concentrate on the harder or more specific cases within that range, and tend to see a higher volume of patients with breast cancer, colorectal cancer, lung cancer, lymphomas, melanoma, and pancreatic cancer.
How does Convene match me with a top Medical Oncology oncologist?
Convene Health evaluates oncologists on peer recognition, clinical leadership, published research, institutional affiliations, and patient feedback. When you complete an intake, our care team reviews your history and matches you with a vetted Medical Oncology oncologist whose focus aligns with your case. Membership covers priority appointment coordination; the match itself is free.